The high concentration of DPP-4 expressed on keratinocytes and the fact that DPP-4 inhibition suppresses keratinocyte proliferation in vitro, and restores partially keratinocyte differentiation in vivo [30], support a potential role for DPP-4 inhibition therapy in the treatment of psoriasis. This evidence concerns the gene DPP4 and psoriasis.